Genetic epidemiology of type 2 diabetes and cardiovascular diseases in Africa

Progress in Cardiovascular Diseases

Volumn 56, Issue 3, 2013, Pages 251-260

  Tekola Ayele, Fasil ^a   Adeyemo, Adebowale A ^a   Rotimi, Charles N ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Africa; Cardiovascular diseases; Epidemiology; Genetics; Type 2 diabetes

Indexed keywords

TRANSCRIPTION FACTOR 7 LIKE 2;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL MEDICINE; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENE IDENTIFICATION; GENE LOCUS; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOMICS; HERITABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; INCIDENCE; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOLOGY; POPULATION GENETICS; PUBLIC HEALTH; RISK FACTOR; TCF7L2 GENE;

AFRICA; BLOOD PRESSURE; BP; CAD; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; CVD; EPIDEMIOLOGY; GENETICS; GENOME WIDE ASSOCIATION STUDY/STUDIES; GWAS; H3AFRICA; HAPMAP; HDL-C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUFS; HUMAN HEREDITY AND HEALTH IN AFRICA INITIATIVE; INTERNATIONAL PROJECT THAT AIMS TO CATALOGUE GENETIC VARIATIONS IN HUMAN BEINGS; LD; LINKAGE DISEQUILIBRIUM A MEASURE OF THE DEGREE OF CORRELATION BETWEEN LOCI ON THE SAME CHROMOSOME; LOD; LOGARITHM OF THE ODDS (LOD) IS A STATISTICAL TEST COMMONLY USED IN GENETIC LINKAGE ANALYSIS. IT COMPARES THE LIKELIHOOD OF OBTAINING THE TEST DATA IF TWO LOCI ARE INDEED LINKED, TO THE LIKELIHOOD OF OBSERVING THE SAME DATA PURELY BY CHANCE; MH-GRID; MINORITY HEALTH GENOMICS AND TRANSLATIONAL RESEARCH BIO-RESPOSITORY DATABASE; NCD; NEGATIVE FAMILY HISTORY; NFH; NON-COMMUNICABLE DISEASES; ODDS RATIO; OR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (GENE); PFH; POSITIVE FAMILY HISTORY; PPARG; RAF; RISK ALLELE FREQUENCY; SBP; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; SSA; SUB SAHARAN AFRICA; SYSTOLIC BLOOD PRESSURE; T2D; TCF7L2; THE HOWARD UNIVERSITY FAMILY STUDY; TRANSCRIPTION FACTOR 7 LIKE 2 (GENE); TYPE 2 DIABETES;

AFRICA; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MOLECULAR EPIDEMIOLOGY; MORBIDITY; RISK FACTORS;

EID: 84887978855     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2013.09.013     Document Type: Article

References (78)

1. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053.
2. Mensah G.A. Ischaemic heart disease in Africa. Heart 2008, 94(7):836-843.
3. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3(11):e442.
4. Jackson F.L. Ethnogenetic layering (EL): an alternative to the traditional race model in human variation and health disparity studies. Ann Hum Biol 2008, 35(2):121-144.
5. Meigs J.B., Cupples L.A., Wilson P.W. Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 2000, 49(12):2201-2207.
6. Hemminki K., Li X., Sundquist K., et al. Familial risks for type 2 diabetes in Sweden. Diabetes Care 2010, 33(2):293-297.
7. Goldfine A.B., Bouche C., Parker R.A., et al. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc Natl Acad Sci U S A 2003, 100(5):2724-2729.
8. Rotimi C., Cooper R., Cao G., et al. Familial aggregation of cardiovascular diseases in African-American pedigrees. Genet Epidemiol 1994, 11(5):397-407.
9. Mbanya J.C., Pani L.N., Mbanya D.N., et al. Reduced insulin secretion in offspring of African type 2 diabetic parents. Diabetes Care 2000, 23(12):1761-1765.
10. Adeleye J.O., Abbiyesuku F.M. Glucose and insulin responses in offspring of Nigerian Type 2 diabetics. Afr J Med Med Sci 2002, 31(3):253-257.
11. Erasmus R.T., Blanco Blanco E., Okesina A.B., et al. Importance of family history in type 2 black South African diabetic patients. Postgrad Med J 2001, 77(907):323-325.
12. Rotimi C.N., Dunston G.M., Berg K., et al. In search of susceptibility genes for type 2 diabetes in West Africa: the design and results of the first phase of the AADM study. Ann Epidemiol 2001, 11(1):51-58.
13. Rotimi C.N., Chen G., Adeyemo A.A., et al. A genome-wide search for type 2 diabetes susceptibility genes in West Africans: the Africa America Diabetes Mellitus (AADM) Study. Diabetes 2004, 53(3):838-841.
14. Yamagata K., Oda N., Kaisaki P.J., et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996, 384(6608):455-458.
15. Rotimi C.N., Chen G., Adeyemo A.A., et al. Genomewide scan and fine mapping of quantitative trait loci for intraocular pressure on 5q and 14q in West Africans. Invest Ophthalmol Vis Sci 2006, 47(8):3262-3267.
16. Chen G., Adeyemo A.A., Zhou J., et al. A genome-wide search for linkage to renal function phenotypes in West Africans with type 2 diabetes. Am J Kidney Dis 2007, 49(3):394-400.
17. Chen G., Adeyemo A.A., Johnson T., et al. A genome-wide scan for quantitative trait loci linked to obesity phenotypes among West Africans. Int J Obes (Lond) 2005, 29(3):255-259.
18. Adeyemo A.A., Johnson T., Acheampong J., et al. A genome wide quantitative trait linkage analysis for serum lipids in type 2 diabetes in an African population. Atherosclerosis 2005, 181(2):389-397.
19. Chen G., Adeyemo A., Zhou J., et al. Genome-wide search for susceptibility genes to type 2 diabetes in West Africans: potential role of C-peptide. Diabetes Res Clin Pract 2007, 78(3):e1-e6.
20. Grant S.F., Thorleifsson G., Reynisdottir I., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38(3):320-323.
21. Helgason A., Palsson S., Thorleifsson G., et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007, 39(2):218-225.
22. Steinthorsdottir V., Thorleifsson G., Reynisdottir I., et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007, 39(6):770-775.
23. Gudmundsson J., Sulem P., Steinthorsdottir V., et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007, 39(8):977-983.
24. Bonilla C., Panguluri R.K., Taliaferro-Smith L., et al. Agouti-related protein promoter variant associated with leanness and decreased risk for diabetes in West Africans. Int J Obes (Lond). 2006, 30(4):715-721.
25. Chen Y., Kittles R., Zhou J., et al. Calpain-10 gene polymorphisms and type 2 diabetes in West Africans: the Africa America Diabetes Mellitus (AADM) Study. Ann Epidemiol 2005, 15(2):153-159.
26. Adeyemo A., Chen G., Zhou J., et al. FTO genetic variation and association with obesity in West Africans and African Americans. Diabetes 2010, 59(6):1549-1554.
27. Chen Y., Huang H., Zhou J., et al. Polymorphism of the endothelial nitric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans. Mol Vis 2007, 13:2142-2147.
28. Olckers A., Towers G.W., van der Merwe A., et al. Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort. Metabolism 2007, 56(5):587-592.
29. Pirie F.J., Motala A.A., Pegoraro R.J., et al. Variants in PPARG, KCNJ11, TCF7L2, FTO, and HHEX genes in South African subjects of Zulu descent with type 2 diabetes. African J Diabetes Med 2010, 18:12-16.
30. Scacchi R., Pinto A., Rickards O., et al. An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits. Nutr Metab Cardiovasc Dis 2007, 17(9):632-641.
31. Gouda H.N., Sagoo G.S., Harding A.H., et al. The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 2010, 171(6):645-655.
32. Ruiz-Narvaez E. Is the Ala12 variant of the PPARG gene an "unthrifty allele"?. J Med Genet 2005, 42(7):547-550.
33. Cauchi S., El Achhab Y., Choquet H., et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med (Berl). 2007, 85(7):777-782.
34. Yi F., Brubaker P.L., Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005, 280(2):1457-1464.
35. Lyssenko V., Lupi R., Marchetti P., et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007, 117(8):2155-2163.
36. Tong Y., Lin Y., Zhang Y., et al. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 2009, 10:15.
37. Guinan K.J. Worldwide distribution of type II diabetes-associated TCF7L2 SNPs: evidence for stratification in Europe. Biochem Genet 2012, 50(3-4):159-179.
38. Adeyemo A., Rotimi C. Genetic variants associated with complex human diseases show wide variation across multiple populations. Public Health Genomics 2010, 13(2):72-79.
39. Klimentidis Y.C., Abrams M., Wang J., et al. Natural selection at genomic regions associated with obesity and type-2 diabetes: East Asians and sub-Saharan Africans exhibit high levels of differentiation at type-2 diabetes regions. Hum Genet 2011, 129(4):407-418.
40. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143-3421.
41. Abd El-Aziz T.A., Hussein Y.M., Mohamed R.H., et al. Renin-angiotensin system genes polymorphism in Egyptians with premature coronary artery disease. Gene 2012, 498(2):270-275.
42. Shaker O.G., Eldemellawy H.H., Kassem H.H. Angiotensinogen gene (M235T) polymorphism and coronary artery disease in the Egyptian population. A genetic association study. Heart Mirror J 2009, 3(2):86-91.
43. Motawi T., Shaker O., Taha M., et al. Endothelial nitric oxide synthase and angiotensinogen gene polymorphism in coronary artery diseases in Egypt. Angiology 2011, 62(2):191-197.
44. Abboud N., Ghazouani L., Kaabi B., et al. Evaluation of the contribution of renin angiotensin system polymorphisms to the risk of coronary artery disease among Tunisians. Genet Test Mol Biomarkers 2010, 14(5):661-666.
45. Cooper R.S., Luke A., Zhu X., et al. Genome scan among Nigerians linking blood pressure to chromosomes 2, 3, and 19. Hypertension 2002, 40(5):629-633.
46. Adeyemo A., Luke A., Wu X., et al. Genetic effects on blood pressure localized to chromosomes 6 and 7. J Hypertens 2005, 23(7):1367-1373.
47. Tayo B.O., Luke A., Zhu X., et al. Association of regions on chromosomes 6 and 7 with blood pressure in Nigerian families. Circ Cardiovasc Genet 2009, 2(1):38-45.
48. Reder N.P., Tayo B.O., Salako B., et al. Adrenergic alpha-1 pathway is associated with hypertension among Nigerians in a pathway-focused analysis. PLoS One 2012, 7(5):e37145.
49. Bouzekri N., Zhu X., Jiang Y., et al. Angiotensin I-converting enzyme polymorphisms, ACE level and blood pressure among Nigerians, Jamaicans and African-Americans. Eur J Hum Genet 2004, 12(6):460-468.
50. Rice T., Cooper R.S., Wu X., et al. Meta-analysis of genome-wide scans for blood pressure in African American and Nigerian samples. The National Heart, Lung, and Blood Institute GeneLink Project. Am J Hypertens 2006, 19(3):270-274.
51. Taylor J.Y., Sampson D., Taylor A.D., et al. Genetic and BMI risks for predicting blood pressure in three generations of West African Dogon women. Biol Res Nurs 2013, 15(1):105-111.
52. Jeck N., Waldegger S., Lampert A., et al. Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension. Hypertension 2004, 43(6):1175-1181.
53. Sile S., Velez D.R., Gillani N.B., et al. CLCNKB-T481S and essential hypertension in a Ghanaian population. J Hypertens 2009, 27(2):298-304.
54. Adeyemo A., Gerry N., Chen G., et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet 2009, 5(7):e1000564.
55. Ehret G.B., Munroe P.B., Rice K.M., et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011, 478(7367):103-109.
56. Fox E.R., Young J.H., Li Y., et al. Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Hum Mol Genet 2011, 20(11):2273-2284.
57. Liu C.T., Garnaas M.K., Tin A., et al. Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. PLoS Genet 2011, 7(9):e1002264.
58. Ding K., Kullo I.J. Geographic differences in allele frequencies of susceptibility SNPs for cardiovascular disease. BMC Med Genet 2011, 12:55.
59. Howard B.V., Davis M.P., Pettitt D.J., et al. Plasma and lipoprotein cholesterol and triglyceride concentrations in the Pima Indians: distributions differing from those of Caucasians. Circulation 1983, 68(4):714-724.
60. Shen G.Q., Rao S., Martinelli N., et al. Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J Hum Genet 2008, 53(2):144-150.
61. Broadbent H.M., Peden J.F., Lorkowski S., et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008, 17(6):806-814.
62. Silander K., Tang H., Myles S., et al. Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease. Genome Med 2009, 1(5):51.
63. Bentley A.R., Doumatey A.P., Chen G., et al. Variation in APOL1 Contributes to Ancestry-Level Differences in HDLc-Kidney Function Association. Int J Nephrol 2012, 2012:748984.
64. Genovese G., Friedman D.J., Ross M.D., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010, 329(5993):841-845.
65. Bentley A.R., Rotimi C. Interethnic variation in lipid profiles: implications for underidentification of African-Americans at risk for metabolic disorders. Expert Rev Endocrinol Metab 2012, 7(6):659-667.
66. Campbell M.C., Tishkoff S.A. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet 2008, 9:403-433.
67. Manolio T.A., Brooks L.D., Collins F.S. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 2008, 118(5):1590-1605.
68. Manolio T.A. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010, 363(2):166-176.
69. Nicolae D.L., Gamazon E., Zhang W., et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 2010, 6(4):e1000888.
70. Pedrotty D.M., Morley M.P., Cappola T.P. Transcriptomic biomarkers of cardiovascular disease. Prog Cardiovasc Dis 2012, 55(1):64-69.
71. McCarthy M.I. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010, 363(24):2339-2350.
72. Sun Q., van Dam R.M., Willett W.C., et al. Prospective study of zinc intake and risk of type 2 diabetes in women. Diabetes Care 2009, 32(4):629-634.
73. Travers M.E., McCarthy M.I. Type 2 diabetes and obesity: genomics and the clinic. Hum Genet 2011, 130(1):41-58.
74. Sesti G., Laratta E., Cardellini M., et al. The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. J Clin Endocrinol Metab 2006, 91(6):2334-2339.
75. Pearson E.R., Donnelly L.A., Kimber C., et al. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study. Diabetes 2007, 56(8):2178-2182.
76. Zhou K., Bellenguez C., Spencer C.C., et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet 2011, 43(2):117-120.
77. Dandara C., Lombard Z., Du Plooy I., et al. Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity. Pharmacogenomics 2011, 12(12):1663-1670.
78. Ramos E., Doumatey A., Elkahloun A.G., et al. Pharmacogenomics, ancestry and clinical decision making for global populations. Pharmacogenomics J 2013, advance online publication, July 9, 2013;. doi:10.1038/tpj.2013.24.